Is this dyspnea because of coronary artery disease? A rare case report of primary neuroendocrine tumor in anterior mediastinum.
Egle RumbinaiteRūta DirsienėDomas VaitiekusLina PoškienėGabrielė ŽūkaitėŠarūnė StankevičienėGintarė ŠakalytėOlivija DobilienėRimantas BenetisPublished in: Perfusion (2023)
Surgery is the treatment of choice for neuroendocrine tumors but the relapse rate ranges between 5% and 30% and is higher (65%) in atypical neuroendocrine tumors and patients with mediastinal node involvement. Despite the poor prognosis of neuroendocrine tumors, the spread to the lymph nodes, the patient continues chemotherapy treatment 49 months after the operation.
Keyphrases
- neuroendocrine tumors
- lymph node
- poor prognosis
- case report
- coronary artery disease
- long non coding rna
- minimally invasive
- heart failure
- squamous cell carcinoma
- early stage
- cardiovascular disease
- cardiovascular events
- coronary artery bypass
- combination therapy
- palliative care
- ultrasound guided
- sentinel lymph node
- smoking cessation
- advanced cancer